Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

CD25+ folliculotropic Sézary syndrome with CD30+ large cell transformation.

Jang MS, Kang DY, Han SH, Park JB, Kim ST, Suh KS.

Australas J Dermatol. 2014 Feb;55(1):e4-8. doi: 10.1111/ajd.12000. Epub 2012 Nov 29. Review.

PMID:
23190349
2.

Mycosis fungoides/Sézary syndrome: report of an unusual case.

Mehta A, Dhungel BM, Khan MF.

J Cutan Pathol. 2006 Sep;33 Suppl 2:12-5.

PMID:
16972946
3.

Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides.

Talpur R, Sui D, Gangar P, Dabaja BS, Duvic M.

Clin Lymphoma Myeloma Leuk. 2016 Jan;16(1):49-56. doi: 10.1016/j.clml.2015.11.010. Epub 2015 Dec 1.

PMID:
26702474
4.

Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases.

Benner MF, Jansen PM, Vermeer MH, Willemze R.

Blood. 2012 Feb 16;119(7):1643-9. doi: 10.1182/blood-2011-08-376319. Epub 2011 Dec 12.

5.
6.

Folliculotropic mycosis fungoides with large-cell transformation presenting as dissecting cellulitis of the scalp.

Gilliam AC, Lessin SR, Wilson DM, Salhany KE.

J Cutan Pathol. 1997 Mar;24(3):169-75.

PMID:
9085153
7.

Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sézary syndrome.

Michaelis S, Kazakov DV, Burg G, Dummer R, Kempf W.

Int J Dermatol. 2006 Mar;45(3):277-9.

PMID:
16533228
8.

Transformation of Sézary syndrome into CD30+ anaplastic large T-cell lymphoma after alemtuzumab therapy with evidence of clonal unity.

Nevet MJ, Zuckerman T, Sahar D, Bergman R.

Am J Dermatopathol. 2015 Jan;37(1):73-7. doi: 10.1097/DAD.0000000000000156.

PMID:
25548993
9.

Brentuximab as a treatment for CD30+ mycosis fungoides and Sézary syndrome.

Mehra T, Ikenberg K, Moos RM, Benz R, Nair G, Schanz U, Haralambieva E, Hoetzenecker W, Dummer R, French LE, Guenova E, Cozzio A.

JAMA Dermatol. 2015 Jan;151(1):73-7. doi: 10.1001/jamadermatol.2014.1629.

PMID:
25317818
10.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):205.e1-16; quiz 221-2. doi: 10.1016/j.jaad.2013.07.049. Review.

PMID:
24438969
11.

Folliculotropic mycosis fungoides (stage IIA) progressing to Sézary syndrome: a case report.

Agar N, Whittaker SJ.

Br J Dermatol. 2008 Nov;159(5):1197-9. doi: 10.1111/j.1365-2133.2008.08802.x. Epub 2008 Sep 1.

PMID:
18764843
12.

Prognostic factors in 105 Japanese cases of mycosis fungoides and Sézary syndrome: clusterin expression as a novel prognostic factor.

Tobisawa S, Honma M, Ishida-Yamamoto A, Saijo Y, Iizuka H.

J Dermatol Sci. 2013 Sep;71(3):160-6. doi: 10.1016/j.jdermsci.2013.04.020. Epub 2013 May 2.

PMID:
23702390
13.

A case of Sézary syndrome associated with cutaneous transformation.

Sakai H, Matsuo S, Matsumoto M, Iizuka H.

J Dermatol. 1996 Oct;23(10):697-702.

PMID:
8973035
14.

Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.

Agar NS, Wedgeworth E, Crichton S, Mitchell TJ, Cox M, Ferreira S, Robson A, Calonje E, Stefanato CM, Wain EM, Wilkins B, Fields PA, Dean A, Webb K, Scarisbrick J, Morris S, Whittaker SJ.

J Clin Oncol. 2010 Nov 1;28(31):4730-9. doi: 10.1200/JCO.2009.27.7665. Epub 2010 Sep 20.

PMID:
20855822
16.

Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.

Vermeer MH, Tensen CP, van der Stoop PM, van Oostveen HW, Lund M, Scheper RJ, Willemze R.

Arch Dermatol. 2001 Jul;137(7):901-5.

PMID:
11453809
18.

Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.

Jawed SI, Myskowski PL, Horwitz S, Moskowitz A, Querfeld C.

J Am Acad Dermatol. 2014 Feb;70(2):223.e1-17; quiz 240-2. doi: 10.1016/j.jaad.2013.08.033. Review.

PMID:
24438970
19.
20.

Fulminant cutaneous T-cell lymphoma and Sézary syndrome.

Lang R, Bernheim J, Bar-Sela S, Joseph D, Ravid M.

Int J Dermatol. 1986 Jan-Feb;25(1):38-43.

PMID:
3485082

Supplemental Content

Support Center